VDP-100 (Fractionalization of Newcastle-Korolchuk IP-NFT)
|
|
22
|
1815
|
May 24, 2023
|
VitaDAO Delegate Applications - Apply now!
|
|
16
|
1361
|
March 9, 2024
|
VitaDAO 2024-2025 Mandate proposal
|
|
13
|
516
|
February 18, 2024
|
VDP-102 [Governance]: Portfolio Management Process
|
|
14
|
1018
|
July 19, 2023
|
VDP-137: Hiring a Chief Scientific Officer (CSO) for VitaDAO
|
|
23
|
616
|
January 17, 2024
|
VDP-93 [Governance]: Proposal to Revise Governance Workflow
|
|
22
|
1095
|
July 19, 2023
|
VDP 108 [Governance] - Compensation Review
|
|
11
|
845
|
August 16, 2023
|
VDP-106 [Governance] Proposal eligibility criteria to enter the VitaDAO deal-flow funnel
|
|
29
|
1921
|
July 6, 2023
|
VDP-140 - Tokenization of the ArtanBio IP-NFT
|
|
10
|
633
|
January 26, 2024
|
VDP 107 [Governance] - Dealflow Steward Restructuring & Network Steward Preparation
|
|
9
|
966
|
June 30, 2023
|
VDP-111: VITA-FAST Governance and Constitution
|
|
20
|
898
|
July 13, 2023
|
VDP-124 Company building management in VitaDAO
|
|
9
|
625
|
December 22, 2023
|
2024 Election of Working Group Stewards
|
|
19
|
766
|
February 13, 2024
|
VDP-118 [Assessment]: GERO - Machine Learning Platform for Age-Related Disease Targeting & Drug Discovery
|
|
12
|
729
|
September 19, 2023
|
VDP-101 Proposal to Establish an Operating Entity for VitaDAO
|
|
12
|
1114
|
June 9, 2023
|
VDP-105 [Outreach]: Promoting Longevity Discourse in the USA Presidential Election
|
|
9
|
476
|
July 18, 2023
|
VDP-136 Proposal: Compensation Policy Squad Update to VDP-72
|
|
51
|
728
|
February 10, 2024
|
VDP-139 [Funding] Luminova: mtON gene therapy in the aged eye
|
|
33
|
790
|
March 5, 2024
|
VDP-122 [Assessment]: Ora Biomedical - Healthy Aging Therapies For Next Generation Medicine
|
|
14
|
756
|
November 15, 2023
|
VDP-103 [Funding]: Mutation-Specific Codon Suppression for Aging and Longevity
|
|
36
|
1807
|
July 19, 2023
|
VDP-143 [Funding] Fission Pharma - Revised
|
|
22
|
680
|
April 13, 2024
|
VDP-134 VitaDAO <> CryoDAO Partnership
|
|
15
|
678
|
February 10, 2024
|
VDP-109 [Funding]: Web3ification of TLDR longevity research peer review service
|
|
15
|
805
|
July 20, 2023
|
VDP-125 Proposal to Advance Scheibye-Knudsen Lab IP-NFT Asset
|
|
11
|
704
|
November 21, 2023
|
VDP-120 [Assessment]: Oisín Biotechnologies - Genetic Medicines for Health and Longevity
|
|
15
|
871
|
April 18, 2024
|
VDP-144 The Longevist Annual Review
|
|
17
|
253
|
April 16, 2024
|
VDP-133 - retroactive compensation for VitaDAO contributors to VDP-16/Korolchuk/VITA-FAST
|
|
12
|
565
|
December 5, 2023
|
VDP-131 [Assessment] Maxwell Biosciences
|
|
11
|
468
|
December 22, 2023
|
VDP-141 [Funding] Cosmica Bio
|
|
10
|
447
|
February 27, 2024
|
VDP-99: Bridging VITA to Optimism, Arbitrum and Polygon
|
|
7
|
774
|
May 29, 2023
|
Ambassador Program Progress
|
|
0
|
287
|
July 5, 2023
|
VDP-112 [Assessment] Cyclarity - Novel cyclodextrin molecules for multiple aging-related diseases
|
|
3
|
713
|
August 7, 2023
|
VDP-98 [Funding]: ETTA Biotechnology
|
|
7
|
719
|
July 27, 2023
|
VDP-138 - Deciding VitaDAO’s next IPT
|
|
4
|
295
|
January 15, 2024
|
VDP-116 [Funding] Mansarover: discovery platform for bifunctional compounds targeting FGF21+TGFß
|
|
8
|
572
|
August 25, 2023
|
VDP-125 - Rework - Scheibye-Knudsen Lab IP-NFT Asset
|
|
5
|
401
|
November 30, 2023
|
VDP-142 Healthspan XPRIZE Plan
|
|
8
|
293
|
March 20, 2024
|
VDP-119 Proposal to Empower Member Services Squad
|
|
1
|
422
|
October 20, 2023
|
VDP-123 [Assessment] Fission Pharma
|
|
7
|
669
|
December 17, 2023
|
VDP-126 [Assessment] Remedium Bio
|
|
5
|
556
|
November 14, 2023
|
VDP-145 Sell $SAFE for ETH
|
|
3
|
161
|
April 22, 2024
|
DAOStewards Delegation Platform and Communication Thread
|
|
6
|
346
|
December 31, 2023
|
VDP-121 Proposal to Mint 10% of Total Token Supply
|
|
2
|
358
|
October 20, 2023
|
VDP-132 [Funding] Mario Cordero - Multi-inflammasome inhibitors to treat aging and age-related diseases
|
|
7
|
502
|
January 3, 2024
|
VDP-114 VitaDAO's Conference Sponsorship Proposal
|
|
3
|
324
|
August 9, 2023
|
VDP-113 [Governance] - Incentive Structure Framework for IP-NFT Deals and Equity Assessments in VitaDAO
|
|
6
|
430
|
August 7, 2023
|
VDP-146 [Funding] The development of oligonucleotide drugs for healthspan
|
|
6
|
133
|
April 28, 2024
|
VDP-117 Magnaetus Therapeutics
|
|
2
|
525
|
September 13, 2023
|
VDP-129 [Assessment]: Vitalia - a city that builds longevity companies
|
|
4
|
397
|
November 17, 2023
|
VDP-104 [Governance]: Amendment to VDP-100 (Fractionalization of Newcastle-Korolchuk)
|
|
7
|
456
|
June 30, 2023
|